Cargando…

Do Placebo Response Rates from Cessation Trials Inform on Strength of Addictions?

There is an implied assumption that addictions to different substances vary in strength from weak (easier to stop) to strong (harder to stop), though explicit definitions are lacking. Our hypothesis is that the strength of addictions can be measured by cessation rates found with placebo or no treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Robert A., Aubin, Henri-Jean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315081/
https://www.ncbi.nlm.nih.gov/pubmed/22470287
http://dx.doi.org/10.3390/ijerph9010192
_version_ 1782228193158103040
author Moore, Robert A.
Aubin, Henri-Jean
author_facet Moore, Robert A.
Aubin, Henri-Jean
author_sort Moore, Robert A.
collection PubMed
description There is an implied assumption that addictions to different substances vary in strength from weak (easier to stop) to strong (harder to stop), though explicit definitions are lacking. Our hypothesis is that the strength of addictions can be measured by cessation rates found with placebo or no treatment controls, and that a weaker addiction would have a higher cessation rate than a stronger addiction. We report an overview of systematic reviews and meta-analyses of cessation trials, using randomised or quasi-randomised trials and reporting objectively-measured abstinence. The outcome for comparison was quit rates–typically the percentage of participants abstinent according to an objective test of abstinence at six months or longer. Twenty-eight cessation reviews (139,000 participants) were found. Most data came from reviews of smoking cessation in over 127,000 participants, and other reviews each covered a few thousand participants. Few reviews used data from studies shorter than three months, and almost all determined abstinence using objective measures. Cessation rates with placebo in randomised trials using objective measures of abstinence and typically over six months duration were 8% for nicotine, 18% for alcohol, 47% for cocaine, and 44% for opioids. Evidence from placebo cessation rates indicates that nicotine is more difficult to give up than alcohol, cocaine, and opioids. Tobacco is also a severe addiction, with a number of major deleterious health effects in a large number of people.
format Online
Article
Text
id pubmed-3315081
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-33150812012-04-02 Do Placebo Response Rates from Cessation Trials Inform on Strength of Addictions? Moore, Robert A. Aubin, Henri-Jean Int J Environ Res Public Health Article There is an implied assumption that addictions to different substances vary in strength from weak (easier to stop) to strong (harder to stop), though explicit definitions are lacking. Our hypothesis is that the strength of addictions can be measured by cessation rates found with placebo or no treatment controls, and that a weaker addiction would have a higher cessation rate than a stronger addiction. We report an overview of systematic reviews and meta-analyses of cessation trials, using randomised or quasi-randomised trials and reporting objectively-measured abstinence. The outcome for comparison was quit rates–typically the percentage of participants abstinent according to an objective test of abstinence at six months or longer. Twenty-eight cessation reviews (139,000 participants) were found. Most data came from reviews of smoking cessation in over 127,000 participants, and other reviews each covered a few thousand participants. Few reviews used data from studies shorter than three months, and almost all determined abstinence using objective measures. Cessation rates with placebo in randomised trials using objective measures of abstinence and typically over six months duration were 8% for nicotine, 18% for alcohol, 47% for cocaine, and 44% for opioids. Evidence from placebo cessation rates indicates that nicotine is more difficult to give up than alcohol, cocaine, and opioids. Tobacco is also a severe addiction, with a number of major deleterious health effects in a large number of people. MDPI 2012-01-11 2012-01 /pmc/articles/PMC3315081/ /pubmed/22470287 http://dx.doi.org/10.3390/ijerph9010192 Text en © 2012 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Moore, Robert A.
Aubin, Henri-Jean
Do Placebo Response Rates from Cessation Trials Inform on Strength of Addictions?
title Do Placebo Response Rates from Cessation Trials Inform on Strength of Addictions?
title_full Do Placebo Response Rates from Cessation Trials Inform on Strength of Addictions?
title_fullStr Do Placebo Response Rates from Cessation Trials Inform on Strength of Addictions?
title_full_unstemmed Do Placebo Response Rates from Cessation Trials Inform on Strength of Addictions?
title_short Do Placebo Response Rates from Cessation Trials Inform on Strength of Addictions?
title_sort do placebo response rates from cessation trials inform on strength of addictions?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315081/
https://www.ncbi.nlm.nih.gov/pubmed/22470287
http://dx.doi.org/10.3390/ijerph9010192
work_keys_str_mv AT mooreroberta doplaceboresponseratesfromcessationtrialsinformonstrengthofaddictions
AT aubinhenrijean doplaceboresponseratesfromcessationtrialsinformonstrengthofaddictions